Senores Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted a routine quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2025. The certificate was issued by MUFG Intime India (formerly Link Intime), the company's Registrar and Share Transfer Agent. It confirms that all share certificates received for dematerialization during the quarter were processed (accepted or rejected) and the physical certificates were cancelled and the depository's name substituted in the company's register of members within the required timelines. This is a standard procedural filing with no financial numbers disclosed.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or stock price. Investors need not take any action.